This is a limited company view. Sign up for a Free Trial to see everything.

TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.

B2B
B2C
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Boston

Founded

2010

Employees

720

Stage

Public

Total funding

$252M

Last funding

5 years ago

Acquisitions

0

Growth score

726

Mindshare score

103

Scoring

Deals

$91.0M Post IPO Equity

Mar 6, 2013

$60.0M Series A

New Enterprise Associates

May 28, 2010

Employee Growth

Use TESARO's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use TESARO's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

President and CEO
New Enterprise Associates
PriceWaterhouseCoopers
Joe Shapiro Chair for the Study of Oncology and Clinical Research, University of Nebraska Medical Center
General Partner
F.A.C.P.

Similar Companies

DGI Clinical

DGI Clinical is a provider of innovative clinical metric solutions that demonstrate clinically meaningful outcomes of treatments for companies and agencies. For more information visitwww.dgiclinical.com
Pre-Series A|11 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes